Pleural Dynamics, Inc.
Martin Mayse is a distinguished medical professional with extensive experience in the field of pulmonary medicine and technology innovation. Currently serving as the Founder and Chief Executive Officer of Pleural Dynamics, Inc. since December 2019 and Co-Founder, Chief Scientific Officer, and Board Member at Apreo Health since January 2021, Martin has held several significant roles in the medical industry. Previous positions include Chief Technology Officer at NUVAIRA, Inc. from February 2013 to June 2019 and Chief Medical Officer at Innovative Pulmonary Solutions, Inc. from June 2008 to February 2013. Notably, Martin established the Interventional Pulmonology program at Washington University School of Medicine, where Martin served as Director from August 2003 to March 2009. Martin’s academic credentials include a Doctor of Medicine degree from Yale School of Medicine and a Bachelor of Science in Engineering from Wright State University.
This person is not in any teams
This person is not in any offices
Pleural Dynamics, Inc.
Pleural Dynamics is a Minneapolis based medical device start-up focused on developing best in class solutions for chronic, recurrent fluid collections within the body. Our flagship product, ACES (the Automatic Continuous Effusion Shunt), is designed for the treatment of chronic recurrent pleural effusions. Chronic recurrent pleural effusions are a build-up of excess fluid between the lung and chest wall that compresses the lung and weighs on the diaphragm causing debilitating shortness of breath, irritating cough, poor quality of life, and short life expectancy. Recurrent pleural effusions affect approximately 660,000 new people in US and Europe each year and represents a $1.5B annual market opportunity for Pleural Dynamics. The current treatment options are cumbersome, costly, and based on decades old technology. ACES utilizes normal breathing motion to automatically pump pleural effusion fluid out of the chest and into the abdomen where it is quickly and safely reabsorbed by the body. This action provides continuous relief of patient symptoms while simultaneously decreasing caregiver labor, infection risk, and overall expense.